{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:29Z","timestamp":1792786109156,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JSPS KAKENHI","award":["21K077478"],"award-info":[{"award-number":["21K077478"]}]},{"name":"Young Investigator Grant of Pediatric Rheumatology Association of Japan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disease characterized by sterile bone inflammation; however, its pathophysiology is poorly understood. Thus, this study aimed to characterize the serum proteomic profiles of patients with CRMO to better understand the molecular mechanisms underpinning CRMO pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Proteomic profiling of the sera collected from 11 patients with CRMO (5 patients were in active phase, 6 were in inactive phase) was conducted using liquid chromatography\u2013mass spectrometry. Sera from four children without inflammatory diseases were used as controls. Pathway analysis was performed to identify the upregulated and downregulated proteins in patients with active CRMO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with the control group, 19 and 41 proteins were upregulated and downregulated, respectively, in patients with active CRMO. Pathway and process enrichment analyses revealed that axon guidance was the most enriched category of upregulated proteins in patients with active CRMO, followed by neutrophil degranulation and mitogen-activated protein kinase cascade regulation. In comparison to patients with inactive CRMO, 36 proteins, including 11 keratin proteins, were upregulated and highly enriched in the intermediate filament organization category. Rho GTPase pathway-related proteins were downregulated in ibuprofen-treated patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Proteomic analysis identified upregulated proteins in the sera of patients with acute CRMO. These proteins can be used as biomarkers for disease diagnosis and activity. Furthermore, we anticipate that this study will contribute to a deeper understanding of the pathophysiology of CRMO, which, in turn, will contribute to the discovery of potential novel therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae301","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T09:33:58Z","timestamp":1716284038000},"page":"1138-1146","source":"Crossref","is-referenced-by-count":7,"title":["Serum proteomic profiles of patients with chronic recurrent multifocal osteomyelitis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1553-2539","authenticated-orcid":false,"given":"Jun-ichi","family":"Kawada","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine , Nagoya,","place":["Japan"]},{"name":"Department of Pediatrics, Fujita Health University School of Medicine , Toyoake, Aichi,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine , Nagoya,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Haruta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine , Nagoya,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine , Nagoya,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine , Nagoya,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine , Nagoya,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Torii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine , Nagoya,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"2025030500185048700_keae301-B1","doi-asserted-by":"crossref","first-page":"959575","DOI":"10.3389\/fimmu.2022.959575","article-title":"Chronic recurrent multifocal osteomyelitis. A narrative and pictorial review","volume":"13","author":"Sergi","year":"2022","journal-title":"Front Immunol"},{"key":"2025030500185048700_keae301-B2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/acr.23462","article-title":"Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal antiinflammatory drugs and\/or with active spinal lesions","volume":"70","author":"Zhao","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025030500185048700_keae301-B3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00281-015-0488-2","article-title":"New discoveries in CRMO: IL-1\u03b2, the neutrophil, and the microbiome implicated in disease pathogenesis in Pstpip2-deficient mice","volume":"37","author":"Ferguson","year":"2015","journal-title":"Semin Immunopathol"},{"key":"2025030500185048700_keae301-B4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.immuni.2023.05.014","article-title":"Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"key":"2025030500185048700_keae301-B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12969-016-0109-1","article-title":"Chronic recurrent multifocal osteomyelitis (CRMO) \u2013 advancing the diagnosis","volume":"14","author":"Roderick","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"2025030500185048700_keae301-B6","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/art.24402","article-title":"Clinical score for nonbacterial osteitis in children and adults","volume":"60","author":"Jansson","year":"2009","journal-title":"Arthritis Rheumat"},{"key":"2025030500185048700_keae301-B7","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1016\/S2665-9913(21)00069-2","article-title":"Biomarkers of tolerance in immune-mediated inflammatory diseases: a new era in clinical management?","volume":"3","author":"Baker","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2025030500185048700_keae301-B8","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/art.42082","article-title":"Identification of mitofusin 1 and complement component 1q subcomponent binding protein as mitochondrial targets in systemic lupus erythematosus","volume":"74","author":"Becker","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025030500185048700_keae301-B9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jpids\/piad074","article-title":"Proteomic analysis reveals novel plasma biomarkers for neurological complications in patients with congenital cytomegalovirus infection","volume":"12","author":"Yamaguchi","year":"2023","journal-title":"J Pediatr Infect Dis Soc"},{"key":"2025030500185048700_keae301-B10","doi-asserted-by":"crossref","first-page":"e29450","DOI":"10.1002\/jmv.29450","article-title":"Comparison of plasma proteomic profiles of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and infectious mononucleosis","volume":"96","author":"Haruta","year":"2024","journal-title":"J Med Virol"},{"key":"2025030500185048700_keae301-B11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.1072802","article-title":"Orc6 involved in DNA replication, chromosome segregation, and cytokinesis","volume":"297","author":"Prasanth","year":"2002","journal-title":"Science"},{"key":"2025030500185048700_keae301-B12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12885-023-10763-z","article-title":"ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis","volume":"23","author":"Lin","year":"2023","journal-title":"BMC Cancer"},{"key":"2025030500185048700_keae301-B13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1471-2148-11-235","article-title":"Molecular evolution of the LNX gene family","volume":"11","author":"Flynn","year":"2011","journal-title":"BMC Evol Biol"},{"key":"2025030500185048700_keae301-B14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cbf.3130","article-title":"PDZRN4 acts as a suppressor of cell proliferation in human liver cancer cell lines","volume":"33","author":"Hu","year":"2015","journal-title":"Cell Biochem Funct"},{"key":"2025030500185048700_keae301-B15","first-page":"142","article-title":"Reduced PDZRN4 promotes breast cancer progression and predicts poor prognosis","volume":"12","author":"Lu","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"2025030500185048700_keae301-B16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00418-008-0435-6","article-title":"The human keratins: biology and pathology","volume":"129","author":"Moll","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"2025030500185048700_keae301-B17","doi-asserted-by":"crossref","first-page":"103012","DOI":"10.1016\/j.cis.2023.103012","article-title":"Recent advances in keratin for biomedical applications","volume":"321","author":"Wang","year":"2023","journal-title":"Adv Colloid Interface Sci"},{"key":"2025030500185048700_keae301-B18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12105-010-0227-x","article-title":"Ewing\u2019s family of tumors of the sinonasal tract and maxillary bone","volume":"5","author":"Hafezi","year":"2011","journal-title":"Head Neck Pathol"},{"key":"2025030500185048700_keae301-B19","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1074\/jbc.M117.775023","article-title":"IL-1\u03b2-induced and p38(MAPK)-dependent activation of the mitogen-activated protein kinase-activated protein kinase 2 (MK2) in hepatocytes: signal transduction with robust and concentration-independent signal amplification","volume":"292","author":"Kulawik","year":"2017","journal-title":"J Biol Chem"},{"key":"2025030500185048700_keae301-B20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2017.08.021","article-title":"MicroRNAs and bioactive compounds on TLR\/MAPK signaling in rheumatoid arthritis","volume":"473","author":"Sujitha","year":"2017","journal-title":"Clin Chim Acta"},{"key":"2025030500185048700_keae301-B21","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.3390\/ijms19103004","article-title":"Roles of mitogen-activated protein kinases in osteoclast biology","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2025030500185048700_keae301-B22","first-page":"566","article-title":"Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis","volume":"4","author":"Pargellis","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"2025030500185048700_keae301-B23","doi-asserted-by":"crossref","first-page":"106321","DOI":"10.1016\/j.bioorg.2022.106321","article-title":"PD0325901, an ERK inhibitor, attenuates RANKL-induced osteoclast formation and mitigates cartilage inflammation by inhibiting the NF-\u03baB and MAPK pathways","volume":"132","author":"Jiang","year":"2023","journal-title":"Bioorg Chem"},{"key":"2025030500185048700_keae301-B24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.106.112466","article-title":"A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss","volume":"320","author":"Kirkwood","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"2025030500185048700_keae301-B25","doi-asserted-by":"crossref","first-page":"115704","DOI":"10.1016\/j.bcp.2023.115704","article-title":"Xl019, a novel JAK inhibitor, suppressed osteoclasts differentiation induced by RANKL through MAPK signaling pathway","volume":"215","author":"Mao","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"2025030500185048700_keae301-B26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"2025030500185048700_keae301-B27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1523\/JNEUROSCI.5045-09.2010","article-title":"A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons","volume":"30","author":"Dill","year":"2010","journal-title":"J Neurosci"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae301\/58101205\/keae301.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1138\/58101205\/keae301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1138\/58101205\/keae301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:22:22Z","timestamp":1741116142000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/3\/1138\/7679631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae301","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,5,22]]}}}